[Long-term oncological outcomes after radical prostatectomy in a non-university teaching hospital]
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Radical prostatectomy (RP) offers curative potential for advanced prostate cancer (PCa). Gleason score is the key prognostic factor, with good outcomes achievable in non-university settings.
Area Of Science
- Urology
- Oncology
- Surgical Outcomes
Context
- Radical prostatectomy (RP) is a cornerstone for prostate cancer (PCa) management.
- Quality control in PCa centers relies heavily on evaluating oncological outcomes post-RP.
Purpose
- To assess oncological outcomes following RP at a non-university teaching hospital.
- To compare these outcomes with those reported by high-volume PCa centers.
Summary
- 1,161 patients undergoing RP were stratified into low-risk (localized PCa, PSA ≤ 20 ng/ml, Gleason score ≤ 7b, pN0) and high-risk (locally advanced PCa, PSA > 20 ng/ml, Gleason score ≥ 8, or pN1) groups.
- 10-year survival rates (biochemical recurrence-free, cancer-specific, and overall) differed significantly between risk groups (p<0.05).
- Gleason score emerged as the most significant predictor for cancer-specific survival and biochemical recurrence-free survival. Nodal involvement strongly predicted cancer-specific survival, while age was crucial for overall survival in high-risk patients.
Impact
- Demonstrates that radical prostatectomy can be a viable curative option for selected advanced prostate cancer cases.
- Highlights Gleason score as a critical prognostic factor for predicting patient outcomes after RP.
- Establishes that comparable oncological outcomes to high-volume centers can be achieved in non-university teaching hospital settings.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
